Chimeric Exosomes Co-Activate Immune Response and Tumor Microenvironment for Cancer Immunotherapy

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have developed macrophage–tumor chimeric exosomes that co-activate the immune response and tumor microenvironment to support cancer immunotherapy. Their study was published online in Science Translational Medicine on Octber 13, 2021. The article is titled “Macrophage-Tumor Chimeric Exosomes Accumulate in Lymph Node and Tumor to Activate the Immune Response and the Tumor Microenvironment.”